Arizona

Arizona

Arizona law allows patients with a valid card to possess, use, and grow limited amounts of marijuana. There is also an adult-use law. Arizona recognizes recommendations from other states. Improved testing standards and reduced patient fees will go in effect as of 11/2020.

Arizona’s emergency coronavirus law declared medical marijuana dispensaries essential businesses, authorizing delivery and curbside pickup.

Patient Rights and Civil Protection	97/100
Arrest Protection 40/40 Affirmative Defense 15/15 Parental Rights Protections 8/10 DUI Protections 5/5 Employment Protections 5/5 Explicit Privacy Standards 7/7 Housing Protections 5/5 Does Not Create New Criminal Penalties for Patients 4/5 Organ Transplants 5/5 Reciprocity 3/3
Access to Medicine	81/100
Allows Distribution Programs 33/40 – Allows Access to Dried Flowers 15/15 – Allows Delivery 5/5 – No Sales Tax or Reasonable Sales Tax 4/5 – Allows for a Reasonable Number of Dispensaries 5/5 – Does Not Require Vertical Integration 0/2 – Ownership/Employment Restrictions 1/2 – Provisions for Labor Standards 0/2 – Environmental Impact Regulations 1/2 – Choice of Dispensary Without Restrictions 2/2 Noncommercial Cultivation 10/20 – Personal Cultivation 10/15 – Collective Gardening 0/5 Explicit Right to Edibles/Concentrates/Other Forms 10/10 Does not Impose Bans or Limits on THC 10/10 Does not Impose Bans on CBD 10/10 Local Bans/Zoning 8/10
Ease of Navigation	87/100
Comprehensive Qualifying Conditions 46/50 Adding New Conditions 9/10 – Law/Regulations Allow for New Conditions 5/5 – System Works for Adding New Conditions 4/5 Reasonable Access for Minors 9/10 Reasonable Caregiver Background Checks 3/4 Number of Caregivers 1/2 Patient/Practitioner-Focused Task Force or Advisory Board 0/2 Reasonable Fees (Patients and Caregivers) 10/10 Allows Multiple-Year Registrations 2/2 Reasonable Physician Requirements 3/5 Does Not Classify Cannabis as a Medicine of Last Resort 4/5
Functionality	74/100
Patients Able to Access Medicine at Dispensaries or by Cultivation 50/50 No Significant Administrative or Supply Problems `10/15 Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 7/10 Reasonable Possession Limits 5/5 Reasonable Purchase Limits 4/5 Allows Patients to Medicate Where They Choose 3/5 Covered by Insurance/State Health Aid 0/3 Financial Hardship (Fee Waivers/Discount Medicine) 5/7
Consumer Safety and Provider Requirements	55.69/100
Dispensing 20.02/25 Staff Training 5/5 Standard Operating Procedures 5/5 – Facility Sanitary Conditions 1.25/1.25 – Storage Protocols 1.25/1.25 – Reasonable Security Protocols 1.25/1.25 – Inventory Control 1.25/1.25 Recall Protocol and Adverse Event Reporting 0/5 Product Labeling 5.0/5 – Product Contents, Including Source Material Identification 1.67/1.67 – Allergens 1.67/1.67 – Potency/Compound Identification 1.67/1.67 Required Testing 5.0/5 – Active Compound Identification 1.67/1.67 – Contaminants 1.67/1.67 – Potency 1.67/1.67 Grow/Cultivation 15.34/25 Staff Training 5/5 Standard Operating Procedures 2.84/5 – Facility and Equipment Sanitary Conditions 0.71/0.71 – Workforce Safety Protocols 0/0.71 – Storage Protocols (Short-Term and Long-Term Storage) 0.71/0.71 – Reasonable Security Protocols 0.71/0.71 – Batch and Lot Tracking 0.71/0.71 – Disposal/Waste 0/0.71 – Water Management 0/0.71 Pesticide Guidance 2.5/5 – Pesticide Guidance 2.5/2.5 – Pesticide Labeling 0/2.5 Required Testing 5/5 – Active Ingredient Identification 1.25/1.25 – Contaminants 1.25/1.25 – Potency 1.25/1.25 – Sample Retention 1.25/1.25 Recall Protocol and Adverse Event Reporting 0/5 Manufacturing 5.67/25 Staff Training 0/5 Standard Operating Procedures 3/5 – Facility and Equipment Sanitary Conditions 0/1 – Workforce Safety Protocols 0/1 – Storage Protocols 1/1 – Reasonable Security Protocols 1/1 – Batch and Lot Tracking 1/1 Product Labeling 1.67/5 – Product Contents, Including Source Material Identification 0/1.67 – Allergens 0/1.67 – Potency and Compound Information 1.67/1.67 Required Testing 1/5 – Active Ingredient Identification 0/1 – Contaminants 0/1 – Potency 0/1 – Shelf Life Testing 0/1 – Sample Retention 1/1 Recall Protocol and Adverse Event Reporting 0/5 Laboratory Operations 14.66/25 Staff Training 0/5 Method Validation in Accordance with AHP Guidelines 3/5 Result Reporting 5/5 Independent or Third Party 5/5 Standard Operating Procedures and Protocols 1.66/5 – Equipment and Instrument Calibration 0/0.83 – Sample Tracking 0/0.83 – Facility and Equipment Sanitary Conditions 0/0.83 – Disposal/Waste 0.83/0.83 – Storage Protocols 0.83/0.83 – Workforce Safety Protocols 0/0.83
Covid Response	14/20
Delivery Available? 6/6 Curbside Pickup Available? 2/2 Medical Cannabis Essential? 4/7 Telemedicine Available? 0/5
Excerpted from ASA's 2020 State of the States Report.

In This Section

The State of Medical Marijuana in Arizona

The State of Medical Marijuana in Arizona

---

Tweet